Emerald Mutual Fund Advisers Trust’s Treace Medical Concepts TMCI Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,229,128	Closed	-$16M	–	245
2024 Q1	$16M	Buy	1,229,128 +45,189	+4%	+$602K	0.84%	47
2023 Q4	$15.1M	Sell	1,183,939 -10,000	-0.8%	-$101K	0.8%	52
2023 Q3	$15.7M	Buy	1,193,939 +73,064	+7%	+$1.34M	0.94%	39
2023 Q2	$28.7M	Hold	1,120,875	–	–	1.55%	8
2023 Q1	$28.2M	Buy	1,120,875 +174,902	+18%	+$4.11M	1.67%	6
2022 Q4	$21.7M	Buy	945,973 +34,464	+4%	+$794K	1.35%	20
2022 Q3	$20.1M	Sell	911,509 -18,373	-2%	-$355K	1.27%	22
2022 Q2	$13.3M	Buy	929,882 +206,686	+29%	+$3.48M	0.77%	51
2022 Q1	$13.7M	Buy	723,196 +328,544	+83%	+$6.39M	0.6%	64
2021 Q4	$7.36M	Buy	394,652 +144,405	+58%	+$2.98M	0.26%	110
2021 Q3	$6.73M	Hold	250,247	–	–	0.23%	105
2021 Q2	$7.82M	Buy	+250,247	New	+$7.97M	0.26%	119

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TMCI Position: Q2 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 1,229,128 shares — an estimated $16M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $28.7M in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

Emerald Mutual Fund Advisers Trust reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 1,229,128 Treace Medical Concepts shares in Q2 2024, an estimated $16M.
Emerald Mutual Fund Advisers Trust first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
Emerald Mutual Fund Advisers Trust's Treace Medical Concepts position peaked at $28.7M in Q2 2023.
127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2024, filed 6 Aug 2024.